Target intelligence / Profile preview

Microtubule affinity-regulating kinase 2 pseudogene 11 (MARK2P11)

Target: MARK2P11
Molecular classification: Other (pseudogene)

Overview

MARK2 pseudogene 11 (MARK2P11) is a human pseudogene that shares sequence homology with the functional MARK2 gene, microtubule affinity-regulating kinase 2. Unlike the canonical MARK2, which is a serine/threonine kinase involved in cell polarity and microtubule dynamics[1], MARK2P11 does not encode a protein and has not been demonstrated to play an active role in biological processes. Pseudogenes generally do not produce functional proteins, though some may have regulatory roles on gene expression via RNA-mediated mechanisms. There is no evidence that MARK2P11 is a drug target, biomarker, or involved in disease processes, and it is not considered a receptor, enzyme, transporter, or other therapeutic target[2][3][5].

Other names: MARK2P11MAP/microtubule affinity-regulating kinase 2 pseudogene 11Microtubule affinity-regulating kinase 2 pseudogene 11

Mechanism of action

None. MARK2P11 is not a drug target.

Biological functions

None specific to this pseudogene. Pseudogenes can contribute to gene regulation at the RNA level through mechanisms such as competing endogenous RNA (ceRNA), acting as decoys for microRNAs, or through effects on parent gene expression. However, there is no evidence for specific biological functions for MARK2P11 itself.

Disease associations

None currently established. Some pseudogenes can regulate gene expression and play roles in cancer and other diseases by acting as molecular sponges for miRNAs or interfering with parent gene expression[3][5]. MARK2P11 does not have reported disease associations.

Safety considerations

None. As MARK2P11 is not a functional protein or therapeutic target, there are no safety concerns associated with it[2].

Interacting drugs

None. Drug interactions are only relevant for proteins or functional RNAs; MARK2P11 does not encode a targetable molecule[2].

Biomarkers

None reported. Pseudogenes are sometimes explored as biomarkers for cancer or other disease states, but MARK2P11 itself is not described as a biomarker in available literature[2][5].

Beyond the preview

Go deeper on Microtubule affinity-regulating kinase 2 pseudogene 11 (MARK2P11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microtubule affinity-regulating kinase 2 pseudogene 11 (MARK2P11).

Explore the full profile